Document is current
Any future updates will be listed below
-
Authors
Kuzmin, Ivan V. http://orcid.org/0000-0001-6661-9891
Soto Acosta, Ruben
Pruitt, Layne
Wasdin, Perry T. http://orcid.org/0000-0001-7351-2048
Kedarinath, Kritika
Hernandez, Keziah R.
Gonzales, Kristyn A.
Hill, Kharighan
Weidner, Nicole G.
Mire, Chad http://orcid.org/0000-0001-7596-1808
Engdahl, Taylor B. http://orcid.org/0000-0002-6280-4405
Moon, Woohyun J.
Popov, Vsevolod
Crowe, James E. Jr http://orcid.org/0000-0002-0049-1079
Georgiev, Ivelin S. http://orcid.org/0000-0002-6312-7696
Garcia-Blanco, Mariano A.
Abbott, Robert K. http://orcid.org/0000-0003-0335-1175
Bukreyev, Alexander http://orcid.org/0000-0002-0342-4824
-
Funding
Funding for this research was provided by:
University of Texas Medical Branch
- License Information
-
More Information
Article History
Received: 29 July 2023
Accepted: 19 July 2024
First Online: 30 July 2024
Competing interests
: M.A.G.-B. and A.B. declare that they have equity in Emervax, Inc., a company developing and commercializing RNA-based vaccines.
